HomeARCH • CVE
add
Arch Biopartners Inc
Previous close
$1.01
Day range
$1.03 - $1.15
Year range
$0.89 - $1.95
Market cap
76.97M CAD
Avg Volume
49.05K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 313.98K | 19.56% |
Net income | -269.76K | 75.56% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.10K | -29.23% |
Total assets | 104.53K | -88.83% |
Total liabilities | 3.99M | -24.55% |
Total equity | -3.88M | — |
Shares outstanding | 65.51M | — |
Price to book | -16.83 | — |
Return on assets | -236.99% | — |
Return on capital | 43.31% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -269.76K | 75.56% |
Cash from operations | -257.90K | 45.11% |
Cash from investing | — | — |
Cash from financing | 92.54K | -78.42% |
Net change in cash | -165.36K | -303.54% |
Free cash flow | -215.14K | 43.90% |
About
Founded
1983
Headquarters
Website
